Marvin 11060916592D 28 31 0 0 0 0 999 V2000 13.4653 -4.3776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.4653 -3.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8966 -3.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.1767 -4.7895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 12.7413 -4.7895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 11.2767 -4.8019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 14.1767 -3.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.0381 -4.3776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8966 -4.3776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.9453 -4.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.7413 -3.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.1767 -5.6132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.1949 -5.5758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.6205 -3.1376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.0381 -3.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.6068 -4.3026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.0188 -5.5758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7732 -6.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5886 -6.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1671 -4.5273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 14.1767 -2.3055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.6205 -2.3138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.3141 -3.1376 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 16.3237 -3.5495 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.7039 -6.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.0284 -6.9864 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.9536 -3.7304 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.1567 -3.5168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 3 9 2 0 0 0 0 4 1 1 0 0 0 0 5 1 1 0 0 0 0 6 8 1 0 0 0 0 7 2 1 0 0 0 0 8 5 2 0 0 0 0 9 4 1 0 0 0 0 10 16 1 0 0 0 0 11 2 1 0 0 0 0 12 4 1 0 0 0 0 13 17 1 0 0 0 0 14 3 1 0 0 0 0 15 8 1 0 0 0 0 16 6 1 0 0 0 0 17 6 1 0 0 0 0 18 12 1 0 0 0 0 19 12 1 0 0 0 0 20 10 2 0 0 0 0 21 7 2 0 0 0 0 22 14 2 0 0 0 0 23 15 1 0 0 0 0 24 14 1 0 0 0 0 25 13 1 0 0 0 0 26 25 1 0 0 0 0 7 3 1 0 0 0 0 11 15 2 0 0 0 0 19 18 1 0 0 0 0 13 10 1 0 0 0 0 20 27 1 0 0 0 0 27 28 1 0 0 0 0 M END > CHEBI:101853 > gemifloxacin > A 1,4-dihydro-1,8-naphthyridine with a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a substituted pyrrolin-1-yl group at the 7-position. > 3 > 7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid > gemifloxacin > C18H20FN5O4 > 389.38090 > 389.14993 > 0 > CO\N=C1/CN(CC1CN)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1 > InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+ > ZRCVYEYHRGVLOC-HYARGMPZSA-N > 8361408 > 175463-14-6 > 175463-14-6 > DB01155 > D08012 > Gemifloxacin $$$$